Dr. Sriman Swarup, MD, MBA | Triple-Board Oncologist & Healthtech Innovator

About Dr. Swarup

Dr. Sriman Swarup, MD, MBA, is a triple board-certified hematologist-oncologist dedicated to advancing patient care and shaping the future of oncology through innovation. After graduating from Grant Medical College, he pursued a formative stint in Singapore before finding his true calling in oncology at Johns Hopkins Cancer Center. His journey — spanning clinical excellence, leadership, and entrepreneurship — reflects a lifelong commitment to improving outcomes for patients and healthcare systems alike.

As a frontline physician leading over 3,000 patient visits annually, Dr. Swarup also drives meaningful change as the founder of OncoNexus, a healthtech company building AI solutions for oncology clinics. His work has earned national recognition, including being named an ASH Choosing Wisely National Champion (2020) for developing a protocol that improved patient safety and saved his institution over $1 million annually.

A firm believer that technology must measurably enhance patient safety and organizational efficiency, he has led multiple quality-improvement and health IT initiatives, including a diagnostic protocol at Texas Tech that remains in use years later. As a clinician-founder, Dr. Swarup is deeply committed to keeping community oncology clinics sustainable, ensuring physicians are fairly compensated, and using technology to make care more efficient.

Beyond medicine, he enjoys time with his wife and children, traveling, hiking, and fishing.

Driving change through innovation, leadership, and award-winning work

Rethinking HIT: A Fellowship Project That Saved $1M+ Annually

During his fellowship, Dr. Swarup designed and implemented a cross-departmental protocol for diagnosing and managing heparin-induced thrombocytopenia (HIT). Tested and refined over three years, the protocol became an institutional practice that continues to improve patient safety while saving over $1 million annually.

The initiative led to an The initiative led to an 18.8% reduction in immunoassay tests, 50% reduction in SRA tests, 42% reduction in alternative anticoagulation use, a four-day decrease in average hospital stay, and a 49% overall cost reduction, ultimately driving a 94% increase in contribution margin. This work earned him the ASH Choosing Wisely National Champion Award (2020)., ultimately driving a 94% increase in contribution margin. This work earned him the ASH Choosing Wisely National Champion Award (2020).

Transforming Oncology Care using advanced AI with Onconexus

As co-founder of OncoNexus, Dr. Swarup leads clinical design addressing oncology burnout, systemic inefficiency, and administrative overload. The platform leverages advanced AI to streamline complex workflows such as clinical documentation, billing, and task management; enabling physicians to reclaim valuable time, and ultimately focus more meaningfully on patient care and outcomes.

University of Arizona Center for Innovation Sponsored Launch Awardee (2025)

American Society of Hematology Choosing Wisely National Champion (2020)

Hemostasis & Thrombosis Research Society Research Colloquium Award (2020)